JP2015511228A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015511228A5 JP2015511228A5 JP2014555250A JP2014555250A JP2015511228A5 JP 2015511228 A5 JP2015511228 A5 JP 2015511228A5 JP 2014555250 A JP2014555250 A JP 2014555250A JP 2014555250 A JP2014555250 A JP 2014555250A JP 2015511228 A5 JP2015511228 A5 JP 2015511228A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen
- compound according
- methyl
- pharmaceutical composition
- fluorine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1202027.7 | 2012-02-06 | ||
| GBGB1202027.7A GB201202027D0 (en) | 2012-02-06 | 2012-02-06 | Pharmaceutical compounds |
| PCT/EP2013/052182 WO2013117522A1 (en) | 2012-02-06 | 2013-02-04 | Aurora and flt3 kinases modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015511228A JP2015511228A (ja) | 2015-04-16 |
| JP2015511228A5 true JP2015511228A5 (enExample) | 2016-03-17 |
| JP6034880B2 JP6034880B2 (ja) | 2016-11-30 |
Family
ID=45896692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014555250A Expired - Fee Related JP6034880B2 (ja) | 2012-02-06 | 2013-02-04 | オーロラおよびｆｌｔ３キナーゼモジュレーター |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9133180B2 (enExample) |
| EP (1) | EP2812328B1 (enExample) |
| JP (1) | JP6034880B2 (enExample) |
| KR (1) | KR102052780B1 (enExample) |
| CN (1) | CN104169277B (enExample) |
| AU (1) | AU2013218167B2 (enExample) |
| BR (1) | BR112014019254B1 (enExample) |
| CA (1) | CA2863759C (enExample) |
| DK (1) | DK2812328T3 (enExample) |
| ES (1) | ES2560260T3 (enExample) |
| GB (1) | GB201202027D0 (enExample) |
| IL (1) | IL233988A (enExample) |
| MX (1) | MX338481B (enExample) |
| PL (1) | PL2812328T3 (enExample) |
| PT (1) | PT2812328E (enExample) |
| RU (1) | RU2643809C2 (enExample) |
| SG (1) | SG11201404277WA (enExample) |
| WO (1) | WO2013117522A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2522968B2 (ja) | 1987-10-23 | 1996-08-07 | 尾池工業株式会社 | 印刷回路転写箔およびその製造法 |
| JP7365332B2 (ja) * | 2017-08-07 | 2023-10-19 | ジョイント・ストック・カンパニー “バイオキャド” | Ｃｄｋ８／１９阻害薬としての新規ヘテロ環式化合物 |
| GB201816369D0 (en) | 2018-10-08 | 2018-11-28 | Sareum Ltd | Pharmaceutical compounds |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE794096A (fr) | 1972-08-07 | 1973-05-16 | Lepetit Spa | Oxazoles 2,4,5-trisubstitues et leur preparation |
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| JPH06310767A (ja) | 1993-04-26 | 1994-11-04 | Nec Corp | 寒剤容器の断熱支持構造 |
| US6218529B1 (en) | 1995-07-31 | 2001-04-17 | Urocor, Inc. | Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer |
| CA2744096C (en) | 1996-07-31 | 2013-07-30 | Laboratory Corporation Of America Holdings | Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
| DE19653355A1 (de) | 1996-12-20 | 1998-06-25 | Dresden Arzneimittel | Neue, antikonvulsiv wirkende Aminoimidazole und Verfahren zu ihrer Herstellung |
| GB0003154D0 (en) | 2000-02-12 | 2000-04-05 | Astrazeneca Uk Ltd | Novel compounds |
| BR0111754A (pt) | 2000-06-28 | 2003-04-29 | Astrazeneca Ab | Uso de um composto, método para inibir aurora 2 quinase em um animal de sangue quente, composto, e, composição farmacêutica |
| AU2479702A (en) | 2000-10-30 | 2002-05-15 | Janssen Pharmaceutica Nv | Tripeptidyl peptidase inhibitors |
| US7361665B2 (en) | 2002-07-09 | 2008-04-22 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
| AU2003902208A0 (en) * | 2003-05-08 | 2003-05-22 | Fujisawa Pharmaceutical Co., Ltd. | Inhibitor of cox |
| ATE465731T1 (de) | 2003-10-23 | 2010-05-15 | Ab Science | 2-aminoaryloxazol-verbindungen als tyrosinkinase- hemmer |
| KR101792651B1 (ko) * | 2004-05-14 | 2017-11-20 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | 아우로라 키나아제의 억제에 의해 유사분열 진행을 억제하기 위한 화합물 및 그 화합물을 포함하는 약학적 조성물 |
| GB0504753D0 (en) | 2005-03-08 | 2005-04-13 | Astrazeneca Ab | Chemical compounds |
| CA2623327A1 (en) | 2005-10-07 | 2007-04-19 | Kissei Pharmaceutical Co., Ltd. | Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| DK200600313A (da) | 2006-03-03 | 2006-03-13 | Novo Nordisk As | Treating type 2 diabetes or metabolic syndrome with an interleukin 1beta inhibitor or an interleukin 1beta synthesis or release inhibitor |
| WO2007131953A1 (en) | 2006-05-12 | 2007-11-22 | Ab Science | A new process for the synthesis of 2-aminoxazole compounds |
| US20090093452A1 (en) | 2006-08-24 | 2009-04-09 | Pfizer Inc. | Pyrrole, Thiophene, Furan, Imidazole, Oxazole, and Thiazole Derivatives |
| JO2701B1 (en) * | 2006-12-21 | 2013-03-03 | جلاكسو جروب ليميتد | Vehicles |
| GB0709031D0 (en) * | 2007-05-10 | 2007-06-20 | Sareum Ltd | Pharmaceutical compounds |
| EP2278969B1 (en) | 2008-04-21 | 2013-02-13 | Merck Sharp & Dohme Corp. | Inhibitors of Janus kinases |
| GB0820819D0 (en) | 2008-11-13 | 2008-12-24 | Sareum Ltd | Pharmaceutical compounds |
| EP2320293A1 (en) * | 2009-11-05 | 2011-05-11 | Koninklijke Philips Electronics N.V. | Sleep element for improving the sleep of a person |
| CN102812022B (zh) * | 2010-01-12 | 2016-02-03 | Ab科学有限公司 | 噻唑和噁唑激酶抑制剂 |
| US9062038B2 (en) | 2010-08-11 | 2015-06-23 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| ES2566205T3 (es) | 2012-03-02 | 2016-04-11 | Sareum Limited | Inhibidores de quinasa TYK2 |
-
2012
- 2012-02-06 GB GBGB1202027.7A patent/GB201202027D0/en not_active Ceased
-
2013
- 2013-02-04 WO PCT/EP2013/052182 patent/WO2013117522A1/en not_active Ceased
- 2013-02-04 CA CA2863759A patent/CA2863759C/en active Active
- 2013-02-04 CN CN201380013544.5A patent/CN104169277B/zh not_active Expired - Fee Related
- 2013-02-04 AU AU2013218167A patent/AU2013218167B2/en not_active Ceased
- 2013-02-04 US US14/376,729 patent/US9133180B2/en active Active
- 2013-02-04 BR BR112014019254-5A patent/BR112014019254B1/pt not_active IP Right Cessation
- 2013-02-04 SG SG11201404277WA patent/SG11201404277WA/en unknown
- 2013-02-04 ES ES13702642.3T patent/ES2560260T3/es active Active
- 2013-02-04 PT PT137026423T patent/PT2812328E/pt unknown
- 2013-02-04 MX MX2014009323A patent/MX338481B/es active IP Right Grant
- 2013-02-04 PL PL13702642T patent/PL2812328T3/pl unknown
- 2013-02-04 JP JP2014555250A patent/JP6034880B2/ja not_active Expired - Fee Related
- 2013-02-04 RU RU2014131784A patent/RU2643809C2/ru active
- 2013-02-04 DK DK13702642.3T patent/DK2812328T3/en active
- 2013-02-04 KR KR1020147024086A patent/KR102052780B1/ko active Active
- 2013-02-04 EP EP13702642.3A patent/EP2812328B1/en active Active
-
2014
- 2014-08-05 IL IL233988A patent/IL233988A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017008088A5 (enExample) | ||
| JP2017524013A5 (enExample) | ||
| JP2016518328A5 (enExample) | ||
| MX2015001571A (es) | Compuestos de anillo en puente como inhibidores del virus de la hepatitis c (hcv) y sus aplicaciones farmaceuticas. | |
| CN109715626A (zh) | 作为fgfr抑制剂的杂环化合物 | |
| JP2016501221A5 (enExample) | ||
| CN107548391A (zh) | 嘧啶或吡啶类化合物、其制备方法和医药用途 | |
| JP2015537020A5 (enExample) | ||
| JP2016040288A5 (enExample) | ||
| JP2016515561A5 (enExample) | ||
| RU2018113718A (ru) | Новые соединения | |
| JP2015508103A5 (enExample) | ||
| JP2017518334A5 (enExample) | ||
| JP2013502441A5 (enExample) | ||
| JP2016522835A5 (enExample) | ||
| JP2015514808A5 (enExample) | ||
| JP2017514910A5 (enExample) | ||
| JP2015533176A5 (enExample) | ||
| JP2016501250A5 (enExample) | ||
| JP2013542261A5 (enExample) | ||
| ME02838B (me) | 3,4-dihidroizokinolin-2(1h)-ilni spojevi | |
| JP2017517538A5 (enExample) | ||
| JP2018501215A5 (enExample) | ||
| JP2016501838A5 (enExample) | ||
| JP2015520770A5 (enExample) |